Intervoke

Lymphir by Citius Pharma 

Prev Next
Previous

LivaNova Advanced Circulatory Support

Next medical animation of Intervoke created a 2D mechanism of action animation for Rezolute Bio to explain how Ersodetug works in patients with hyperinsulinism (HI). HI causes excessive insulin production, leading to dangerously low blood sugar. Ersodetug, a monoclonal antibody, rebalances insulin signaling to stabilize blood glucose levels, even when insulin is too high.

Ersodetug by Rezolute Bio

Intervoke created a cinematic-quality Mechanism of Action animation for Lymphir, an FDA-approved therapy for relapsed or refractory Stage I–III cutaneous T-cell lymphoma (CTCL). Lymphir targets malignant T cells and immunosuppressive Tregs, delivering a diphtheria toxin fragment to disrupt protein synthesis and induce apoptosis.

Keywords: Animation, Advertising / Marketing, Patient Education, Oncology, Mechanism of Action (MOA)

Intervoke